128 related articles for article (PubMed ID: 24761452)
1. Neutrophil numerals.
Bitar C; Saba N
Blood; 2014 Mar; 123(11):1635. PubMed ID: 24761452
[No Abstract] [Full Text] [Related]
2. Deletion of the der(9q) in chronic myeloid leukemia: the controversy continues.
Godley LA
Leuk Lymphoma; 2009 Jun; 50(6):871-2. PubMed ID: 19479615
[No Abstract] [Full Text] [Related]
3. Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case.
Zeidan A; Kakati S; Anderson B; Barcos M; Wetzler M
Cancer Genet Cytogenet; 2007 Jul; 176(2):169-71. PubMed ID: 17656263
[No Abstract] [Full Text] [Related]
4. Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate.
Takahashi N; Kameoka Y; Tagawa H; Saitoh H; Yoshioka T; Fujishima N; Kitabayashi A; Takahashi K; Hirokawa M; Sawada K
Int J Hematol; 2010 Oct; 92(3):559-61. PubMed ID: 20838959
[No Abstract] [Full Text] [Related]
5. ETV6-ABL1-positive "chronic myeloid leukemia": clinical and molecular response to tyrosine kinase inhibition.
Perna F; Abdel-Wahab O; Levine RL; Jhanwar SC; Imada K; Nimer SD
Haematologica; 2011 Feb; 96(2):342-3. PubMed ID: 21193423
[No Abstract] [Full Text] [Related]
6. Presence of complex t(6;9;22;15) four-way chromosome rearrangement plus rare t(1;6) translocation with favorable response to imatinib therapy in chronic myelogenous leukemia.
Lu CM; Zhou L; Feng S; Kohn PH; Qi Z; Yu J
Leuk Lymphoma; 2011 Nov; 52(11):2182-4. PubMed ID: 21718138
[No Abstract] [Full Text] [Related]
7. Chronic myeloid leukemia with a novel four-way t(6;13;9;22)(p21;q32;q34;q11.2) successfully treated with imatinib mesylate.
Kubota Y; Waki M
Cancer Genet Cytogenet; 2010 Sep; 201(2):135-6. PubMed ID: 20682400
[No Abstract] [Full Text] [Related]
8. A novel 5-way translocation t(9;11;13;19;22) in a case of chronic-phase chronic myeloid leukemia.
Vaidya S; Joshi D; Ghosh K; Chakrabarti P; Vundinti BR
Hum Pathol; 2013 Oct; 44(10):2365-9. PubMed ID: 23759653
[TBL] [Abstract][Full Text] [Related]
9. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment.
Bhatia R; Holtz M; Niu N; Gray R; Snyder DS; Sawyers CL; Arber DA; Slovak ML; Forman SJ
Blood; 2003 Jun; 101(12):4701-7. PubMed ID: 12576334
[TBL] [Abstract][Full Text] [Related]
10. A case with coexistence of major and minor BCR/ABL fusion transcript at lymphoblastic crisis of chronic myelogenous leukemia in patients with major BCR/ABL positivity during chronic phase.
Park SH; Chi HS; Cho YU; Jang S; Park CJ; Im HJ
Ann Lab Med; 2013 Jan; 33(1):80-3. PubMed ID: 23301228
[No Abstract] [Full Text] [Related]
11. Karyotype changes during long-term targeted therapy of chronic myeloid leukemia with imatinib.
Pieńkowska-Grela B; Rygier J; Woroniecka R; Grygalewicz B; Pastwińska A; Krawczyk P; Ceglerek B; Seferyńska I; Sikorska A; Konopka L
Leuk Lymphoma; 2009 Jun; 50(6):952-65. PubMed ID: 19479611
[TBL] [Abstract][Full Text] [Related]
12. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics.
Kurzrock R; Kantarjian HM; Druker BJ; Talpaz M
Ann Intern Med; 2003 May; 138(10):819-30. PubMed ID: 12755554
[TBL] [Abstract][Full Text] [Related]
13. Imatinib mesylate noncompliance simulating chronic myeloid leukemia resistance.
Sandoval C; Giamelli J; Jayabose S
J Pediatr Hematol Oncol; 2003 Jun; 25(6):507-8. PubMed ID: 12794534
[No Abstract] [Full Text] [Related]
14. Chronic myeloid leukemia arising from acute myeloid leukemia: response to imatinib mesylate with favorable outcome.
Xu XH; Huang LS; Yang J; Yu T; Tong JF; Yuan XG; Zhao XY
Leuk Lymphoma; 2013 Jan; 54(1):195-7. PubMed ID: 22574970
[No Abstract] [Full Text] [Related]
15. Leukemia cells fall on their swords.
Rutherford A
Trends Mol Med; 2001 Apr; 7(4):149. PubMed ID: 11286930
[No Abstract] [Full Text] [Related]
16. Molecular response in CML: where is the bar?
Baccarani M; Soverini S
Blood; 2014 Jul; 124(4):469-71. PubMed ID: 25061165
[TBL] [Abstract][Full Text] [Related]
17. p190(BCR-ABL) rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22).
Cividin M; Brizard F; Sorel N; Renaud M; Guilhot F; Brizard A
Leuk Res; 2004 Jan; 28(1):97-9. PubMed ID: 14630086
[TBL] [Abstract][Full Text] [Related]
18. Leukemia. Q&A highlights.
Frame D; Sessions J; Fausel C
Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S22. PubMed ID: 18056929
[No Abstract] [Full Text] [Related]
19. Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.
Hwang YY; Tse E; So JC; Wan TS; Kwong YL
Am J Hematol; 2009 May; 84(5):302-5. PubMed ID: 19338042
[No Abstract] [Full Text] [Related]
20. [Treatment of chronic myelogenous leukemia by using imatinib].
Jinnai I
Nihon Naika Gakkai Zasshi; 2005 Sep; 94(9):1819-24. PubMed ID: 16223141
[No Abstract] [Full Text] [Related]
[Next] [New Search]
